IOL CHEMICALS & PHARM. | AUROBINDO PHARMA | IOL CHEMICALS & PHARM./ AUROBINDO PHARMA |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 12.4 | 22.9 | 54.2% | View Chart |
P/BV | x | 1.4 | 2.4 | 59.5% | View Chart |
Dividend Yield | % | 1.1 | 0.3 | 399.4% |
IOL CHEMICALS & PHARM. AUROBINDO PHARMA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
AUROBINDO PHARMA Mar-23 |
IOL CHEMICALS & PHARM./ AUROBINDO PHARMA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 715 | 75.1% | |
Low | Rs | 272 | 397 | 68.5% | |
Sales per share (Unadj.) | Rs | 377.6 | 424.2 | 89.0% | |
Earnings per share (Unadj.) | Rs | 23.7 | 32.9 | 72.0% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 54.1 | 58.3% | |
Dividends per share (Unadj.) | Rs | 4.00 | 3.00 | 133.3% | |
Avg Dividend yield | % | 1.0 | 0.5 | 183.3% | |
Book value per share (Unadj.) | Rs | 256.8 | 458.1 | 56.1% | |
Shares outstanding (eoy) | m | 58.71 | 585.94 | 10.0% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 1.3 | 81.7% | |
Avg P/E ratio | x | 17.1 | 16.9 | 101.0% | |
P/CF ratio (eoy) | x | 12.8 | 10.3 | 124.8% | |
Price / Book Value ratio | x | 1.6 | 1.2 | 129.8% | |
Dividend payout | % | 16.9 | 9.1 | 185.1% | |
Avg Mkt Cap | Rs m | 23,743 | 325,753 | 7.3% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 35,223 | 4.8% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 248,554 | 8.9% | |
Other income | Rs m | 256 | 2,906 | 8.8% | |
Total revenues | Rs m | 22,427 | 251,460 | 8.9% | |
Gross profit | Rs m | 2,257 | 37,070 | 6.1% | |
Depreciation | Rs m | 462 | 12,446 | 3.7% | |
Interest | Rs m | 165 | 1,405 | 11.7% | |
Profit before tax | Rs m | 1,887 | 26,125 | 7.2% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 6,849 | 7.2% | |
Profit after tax | Rs m | 1,391 | 19,277 | 7.2% | |
Gross profit margin | % | 10.2 | 14.9 | 68.2% | |
Effective tax rate | % | 26.2 | 26.2 | 100.1% | |
Net profit margin | % | 6.3 | 7.8 | 80.9% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 214,599 | 4.5% | |
Current liabilities | Rs m | 5,025 | 114,938 | 4.4% | |
Net working cap to sales | % | 20.9 | 40.1 | 52.2% | |
Current ratio | x | 1.9 | 1.9 | 103.0% | |
Inventory Days | Days | 43 | 21 | 209.9% | |
Debtors Days | Days | 8 | 66 | 12.7% | |
Net fixed assets | Rs m | 11,017 | 176,668 | 6.2% | |
Share capital | Rs m | 587 | 586 | 100.2% | |
"Free" reserves | Rs m | 14,490 | 267,813 | 5.4% | |
Net worth | Rs m | 15,077 | 268,399 | 5.6% | |
Long term debt | Rs m | 0 | 6,190 | 0.0% | |
Total assets | Rs m | 20,684 | 392,125 | 5.3% | |
Interest coverage | x | 12.5 | 19.6 | 63.6% | |
Debt to equity ratio | x | 0 | 0 | 0.0% | |
Sales to assets ratio | x | 1.1 | 0.6 | 169.1% | |
Return on assets | % | 7.5 | 5.3 | 142.6% | |
Return on equity | % | 9.2 | 7.2 | 128.5% | |
Return on capital | % | 13.6 | 10.0 | 135.7% | |
Exports to sales | % | 26.7 | 33.7 | 79.4% | |
Imports to sales | % | 0 | 15.3 | 0.0% | |
Exports (fob) | Rs m | 5,930 | 83,703 | 7.1% | |
Imports (cif) | Rs m | NA | 38,060 | 0.0% | |
Fx inflow | Rs m | 5,930 | 85,483 | 6.9% | |
Fx outflow | Rs m | 6,052 | 41,447 | 14.6% | |
Net fx | Rs m | -122 | 44,036 | -0.3% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | 23,868 | 5.1% | |
From Investments | Rs m | -1,200 | -39,778 | 3.0% | |
From Financial Activity | Rs m | -41 | 18,144 | -0.2% | |
Net Cashflow | Rs m | -18 | 2,298 | -0.8% |
Indian Promoters | % | 48.2 | 48.8 | 98.8% | |
Foreign collaborators | % | 0.0 | 3.1 | - | |
Indian inst/Mut Fund | % | 2.5 | 41.3 | 6.1% | |
FIIs | % | 2.2 | 20.7 | 10.5% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 48.2 | 107.6% | |
Shareholders | 134,235 | 241,944 | 55.5% | ||
Pledged promoter(s) holding | % | 0.0 | 20.1 | - |
Compare IOL CHEMICALS & PHARM. With: SUN PHARMA DIVIS LABORATORIES CIPLA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | Aurobindo Pharma | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 0.60% | 1.49% | 1.49% |
1-Month | -9.00% | 5.62% | -0.45% |
1-Year | 30.34% | 112.38% | 62.32% |
3-Year CAGR | -13.32% | 7.66% | 18.28% |
5-Year CAGR | 13.48% | 7.11% | 19.86% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the Aurobindo Pharma share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of Aurobindo Pharma the stake stands at 51.8%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of Aurobindo Pharma.
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
Aurobindo Pharma paid Rs 3.0, and its dividend payout ratio stood at 9.1%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of Aurobindo Pharma.
For a sector overview, read our pharmaceuticals sector report.
Asian markets traded lower, while the US stock indices ended higher overnight with the S&P 500 hitting a record closing high ahead of key economic data.